Siren, L.L.C. Kymera Therapeutics, Inc. Transaction History
Siren, L.L.C.
- $2 Trillion
- Q3 2024
A detailed history of Siren, L.L.C. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 2,969,733 shares of KYMR stock, worth $118 Million. This represents 7.03% of its overall portfolio holdings.
Number of Shares
2,969,733Holding current value
$118 Million% of portfolio
7.03%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
64.3MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$263 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$237 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$204 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$194 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$188 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.17B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...